Xeris Biopharma Holdings, Inc. (XERS)
8.74
0.00 (0.00%)
USD |
NASDAQ |
Aug 25, 16:00
8.75
+0.01
(+0.11%)
After-Hours: 19:59
Xeris Biopharma Holdings 1 Year Total Returns (Daily) : 12.48% for Aug. 25, 2026
1 Year Total Returns (Daily) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| August 25, 2026 | 12.48% |
| August 24, 2026 | 12.77% |
| August 21, 2026 | 14.62% |
| August 20, 2026 | 13.61% |
| August 19, 2026 | 19.29% |
| August 18, 2026 | 20.24% |
| August 17, 2026 | 10.94% |
| August 14, 2026 | 17.81% |
| August 13, 2026 | 14.42% |
| August 12, 2026 | 16.30% |
| August 11, 2026 | 16.53% |
| August 10, 2026 | 16.81% |
| August 07, 2026 | 20.15% |
| August 06, 2026 | 34.06% |
| August 05, 2026 | 47.99% |
| August 04, 2026 | 47.30% |
| August 03, 2026 | 51.12% |
| July 31, 2026 | 58.74% |
| July 30, 2026 | 64.13% |
| July 29, 2026 | 67.60% |
| July 28, 2026 | 62.52% |
| July 27, 2026 | 63.55% |
| July 24, 2026 | 60.93% |
| July 23, 2026 | 64.26% |
| July 22, 2026 | 63.67% |
| Date | Value |
|---|---|
| July 21, 2026 | 70.82% |
| July 20, 2026 | 68.30% |
| July 17, 2026 | 68.26% |
| July 16, 2026 | 65.21% |
| July 15, 2026 | 64.46% |
| July 14, 2026 | 52.21% |
| July 13, 2026 | 59.69% |
| July 10, 2026 | 58.25% |
| July 09, 2026 | 61.42% |
| July 08, 2026 | 81.76% |
| July 07, 2026 | 90.21% |
| July 06, 2026 | 76.21% |
| July 02, 2026 | 75.05% |
| July 01, 2026 | 71.67% |
| June 30, 2026 | 69.59% |
| June 29, 2026 | 64.68% |
| June 26, 2026 | 62.24% |
| June 25, 2026 | 57.11% |
| June 24, 2026 | 58.80% |
| June 23, 2026 | 55.17% |
| June 22, 2026 | 52.99% |
| June 18, 2026 | 51.75% |
| June 17, 2026 | 51.98% |
| June 16, 2026 | 56.82% |
| June 15, 2026 | 58.16% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
1 Year Total Returns (Daily) Benchmarks
| Zevra Therapeutics, Inc. | 28.63% |
| Aclaris Therapeutics, Inc. | 263.1% |
| ANI Pharmaceuticals, Inc. | -16.24% |
| Corcept Therapeutics, Inc. | 79.56% |
| Veru, Inc. | -22.35% |